可切除非小细胞肺癌中的肌少症对术后结局的影响
这项回顾性研究纳入328例病理确诊并接受根治性切除的非小细胞肺癌患者,用术前CT测量腰大肌质量指数(PMI)定义肌少症。肌少症患病率为55.8%,与高龄、男性、吸烟、低BMI及术后重大并发症相关;肌少症患者5年生存率为61%,无肌少症者为91%,多因素分析显示肌少症为独立不良预后因素(p=0.019)。
要点
- 肌少症患病率55.8%,男性高于女性,男性随年龄增长而增加。
- 肌少症与术后重大并发症(Clavien-Dindo≥3级)显著相关(p=0.036)。
- 肌少症为独立不良预后因素(p=0.019),5年生存率61%对91%。
核心结论
- 术前CT评估的肌少症可预测可切除非小细胞肺癌患者术后重大并发症和预后。
研究设计与样本
- 回顾性研究纳入328例病理确诊非小细胞肺癌并接受根治性切除的患者(2005年1月至2017年4月)。
- 术前CT测量第三腰椎水平腰大肌质量指数(PMI,cm2/m2),肌少症定义为男性PMI<6.36 cm2/m2、女性<3.92 cm2/m2。
主要发现
- 肌少症患病率55.8%(183例),与年龄增长、男性、吸烟、较低BMI及术后重大并发症(Clavien-Dindo≥3级,p=0.036)显著相关。
- 肌少症患者5年生存率为61%,无肌少症者为91%。
- 多因素分析显示肌少症为独立不良预后因素(p=0.019)。
- 男性肌少症患病率高于女性,男性患病率随年龄增长而增加,而女性70岁以上患病率未增加。
关键数值与推荐
- 肌少症定义:男性PMI<6.36 cm2/m2,女性PMI<3.92 cm2/m2(基于健康受试者PMI值)。
- 术后重大并发症定义为Clavien-Dindo分级≥3级。
临床怎么用
- 术前CT测量的PMI可用于识别肌少症,辅助预测可切除非小细胞肺癌患者术后重大并发症和预后。
- 结果可能为术前管理提供重要信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Skeletal muscle depletion, referred to as sarcopenia, has recently been identified as a risk factor for poor outcomes in various malignancies. However, the prognostic significance of sarcopenia in patients with NSCLC after surgery has not been adequately determined. This study investigated the impact of sarcopenia in patients undergoing pulmonary resection for lung cancer. METHODS: This retrospective study consisted of 328 patients with pathologically confirmed NSCLC who underwent curative resection between January 2005 and April 2017. Preoperative computed tomography imaging at the third lumbar vertebrae level was assessed to measure the psoas muscle mass index (PMI, cm2/m2). Sarcopenia was defined as a cutoff value of PMI less than 6.36 cm2/m2 for males and 3.92 cm2/m2 for females, based on PMI values from "healthy" subjects. RESULTS: The median patient age was 71 years and 59% were male. Sarcopenia was present in 183 (55.8%) and was significantly related with increasing age (p < 0.001), being male (p < 0.001), smoking habit (p < 0.001), lower body mass index (p < 0.001), and postoperative major complication (Clavien-Dindo grade ≥3, p = 0.036). The prevalence of sarcopenia was higher in men than in women, and the prevalence increased with age in men, whereas the prevalence did not increase in females older than 70 years. The 5-year survival rate was 61% in patients with sarcopenia and 91% in those without. Multivariate analysis revealed that sarcopenia was an independent unfavorable prognostic factor (p = 0.019). CONCLUSIONS: Sarcopenia as determined using preoperative computed tomography could be used to predict postoperative major complication and prognosis in patients with resected NSCLC. Our results may provide some important information for preoperative management.
引用
- Nakamura R, Inage Y, Tobita R, et al. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes. J Thorac Oncol. 2018. PMID: 29751134. doi:10.1016/j.jtho.2018.04.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。